By John Kennedy ( December 22, 2015, 7:04 PM EST) -- A teacher's retirement fund that alleges Valeant Pharmaceuticals fraudulently inflated its stock price, causing the fund to lose more than $90 million, asked a New Jersey federal court Monday to consolidate four related putative class actions and name it lead plaintiff with Robbins Geller Rudman & Dowd LLP as lead counsel....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.